FDA Adverse Event Malfunction Summary report: N

ALINITY I CMV IGG REAGENT KIT

MDR report key: 24616196 · Received March 17, 2026

Report

Report Number
3008344661-2026-00058
Event Type
Malfunction
Date Received
March 17, 2026
Date of Event
November 25, 2025
Report Date
May 13, 2026
Manufacturer
ABBOTT IRELAND DIAGNOSTICS DIVISION
Product Code
LFZ
UDI-DI
00380740129798
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

SECTION A PATIENT INFORMATION: REFER TO SECTION B5 FOR COMPLETE PATIENT INFORMATION. THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 7P42 THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 7P42-24/-33, AND 510K/PMA/BLA OF K220949. AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE.

Description of Event or Problem · 0

THE CUSTOMER OBSERVED FALSE POSITIVE ALINITY I CMV IGG RESULTS COMPARED TO ROCHE TECHNIQUE. SID (B)(6), (FEMALE) ON (B)(6) 2025, GENERATED ALINITY I CMV IGG REACTIVE OF 21.7 AU/ML. ADDITIONAL TESTING OF ALINITY I CMV IGM OF 1.25 INDEX, LOW POSITIVE. NO AVIDITY TESTING WAS PERFORMED. THE PATIENT WAS NOT PREGNANT ON THIS DATE. THE SAME PATIENT, USING ID (B)(6), ON (B)(6) 2026, GENERATED ALINITY I CMV IGG REACTIVE OF 24.1 AU/ML. ADDITIONAL TESTING OF ALINITY I CMV IGM OF 1.27 INDEX, LOW POSITIVE. THE SAMPLE WAS SENT TO ANOTHER LAB FOR AVIDITY TESTING, BECAUSE PATIENT WAS PREGNANT. ROCHE RESULT OF NO CMV IGG, SO AVIDITY COULD NOT BE RUN. THE CUSTOMER RETRIEVED THE SERUM SAMPLE FROM (B)(6) 2025 AND SENT TO ANOTHER LAB FOR AVIDITY TESTING. THE RESULT WAS NO CMV IGG. THE PATIENT IS KNOWN TO HAVE WEAKLY POSITIVE ANTI-CARDIOLIPIN IGM. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
143851 ALINITY I CMV IGG REAGENT KIT ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS LFZ ABBOTT IRELAND DIAGNOSTICS DIVISION 80086FZ00 00380740129798

Patients

Seq Age Sex Outcome Treatment
1